BioPharma

NuclixBio Announces a Collaborative Research Agreement with PharmAbcine

Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA™' to ...

 March 15, 2022 | News

Everest Medicines to further enhance its international commercial footprint

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...

 March 14, 2022 | News

Veristat Expands its Expertise and Scale across Biopharma and Medtech

Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...

 March 08, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

 March 03, 2022 | News

BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development

German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Phar...

 March 01, 2022 | News

Terumo and Corazon Sign Collaboration and Co-Marketing Agreement

Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing...

 February 28, 2022 | News

HitGen , MTPC to discover novel hit compounds for multiple drug targets

During the three-year collaboration, multiple undisclosed targets (including undruggable targets) were screened against HitGen's proprietary DNA encoded ch...

 February 25, 2022 | News

Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...

 February 18, 2022 | News

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...

 February 11, 2022 | News

GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability

The state-of-the-art site marks a significant expansion of the company's advanced  protein and gene platforms, and is designed to provide high quality...

 February 10, 2022 | News

Nanoform signs GMP manufacturing program with TargTex following formulation success

This follows a successful PoC (Proof of Concept) study where the hydrogel formulation developed by Nanoform (CESS®2 technology-based nanoparticles...

 February 07, 2022 | News

Germfree launches novel mobile cleanroom technology for advanced therapies

Germfree’s biomanufacturing platform addresses current industry needs, while de-risking and future-proofing for a rapidly evolving industry. "The ind...

 February 03, 2022 | News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

Dr. Michael Quirmbach, Chief Executive Officer & President of CordenPharma said, "We welcome the three sites and their employees as new members to...

 February 02, 2022 | News

Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa

In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...

 February 01, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close